MENU

FATE Fate Therapeutics Forecast, Technical & Fundamental Analysis

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States... Show more

Industry: #Biotechnology
FATE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
FATE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

FATE is expected to report earnings to rise 3.85% to -27 cents per share on August 05

Fate Therapeutics FATE Stock Earnings Reports
Q2'26
Est.
$-0.27
Q1'26
Beat
by $0.02
Q4'25
Est.
$-0.27
Q3'25
Beat
by $0.03
Q2'25
Beat
by $0.05
The last earnings report on May 13 showed earnings per share of -25 cents, beating the estimate of -28 cents. With 585.88K shares outstanding, the current market capitalization sits at 285.57M.
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
12278 Scripps Summit Drive
Phone
+1 858 875-1800
Employees
161
Web
https://www.fatetherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IEDRX12.930.12
+0.94%
Voya Large Cap Value R
ACEIX11.750.08
+0.69%
Invesco Equity and Income A
CRRRX16.840.02
+0.12%
Columbia Sm Cp Val and Inflection Inst2
EAAAX18.61-0.01
-0.05%
Gabelli Entpr Mergers & Acquisitions AAA
BRSHX15.79-0.08
-0.50%
MFS Blended Research Small Cap Eq C

FATE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, FATE has been loosely correlated with NKTX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if FATE jumps, then NKTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FATE
1D Price
Change %
FATE100%
-2.39%
NKTX - FATE
48%
Loosely correlated
-2.79%
VCYT - FATE
44%
Loosely correlated
-22.52%
PTN - FATE
41%
Loosely correlated
-1.79%
CABA - FATE
40%
Loosely correlated
-1.47%
EDIT - FATE
40%
Loosely correlated
-4.09%
More
Fate Therapeutics (FATE) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com